3rd Quarter - Report

INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION

Firm
Client
Income
—
Expenses
$50,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 1040, the Drug Competition Enhancement Act S. 1041, the Affordable Prescriptions for Patients Act S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S. 43, Skinny Labels, Big Savings Act S.1546, Patent Eligibility Restoration Act S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 708, Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE Patent Rights Act of 2025) Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce Act (SHOP SAFE Act) - not yet reintroduced

LobbyistCovered position, as disclosed
SAMANTHA JAKHELLN AGUAYO —

Contacted: SENATE; U.S. Copyright Office; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. International Trade Commission (ITC); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR)

Bills named: S. 1041 (119th), S. 708 (119th), S. 1040 (119th), S. 43 (119th), S. 1097 (119th), S. 1546 (119th), S. 1553 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.